Multidisciplinary approach to psoriasis in the Spanish National Health System: A social return on investment study

Carretero, G.; Moreno, David; González-Domínguez, Almudena; Ledesma, Albert; Sarquella, Esther; Merino, María; Blanch, Carles

doi:10.33393/grhta.2020.2146

Cited by 8 publications

(6 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a recent study, Carretero et al ( 35 ) analysed the social aspects that would benefit the management of psoriasis within the Spanish healthcare system, including a holistic approach. They estimated that, for every euro invested, a social benefit of 5.04 euros would be obtained.…”

Section: Discussionmentioning

confidence: 99%

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation

et al. 2022

View full text Add to dashboard Cite

Psoriasis is a chronic, systemic inflammatory disease that affects the skin, with a high impact on patients’ quality of life. The aim of this study was to identify and determine the relative importance of unmet needs in the management of moderate-to-severe psoriasis in Spain, from a multi-stakeholder perspective. A mixed method-approach was used to collect information, design a questionnaire and a discrete-choice exercise, and elicit the unmet needs through a multidisciplinary committee composed of 12 experts. A total of 65 unmet needs were identified and categorized into 4 areas: clinical, patient-related, decision-making process, and social. Decision-making process unmet needs were perceived as the most pressing ones, followed by social, clinical and patient-related. Individually, the need to incorporate outcomes that are important to the patients and to have treatments that achieve total clearance with a rapid onset of action and long-term persistence were the most important unmet needs.

show abstract

Section: Discussionmentioning

confidence: 99%

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The Social Return on Investment (SROI) provides the ideal framework to assess the multidimensional impact that such decisions would have relative to the investment required to put them into practice [ 20 – 22 ]. Previous experiences using this method have been used to guide decision-making in multiple healthcare areas such as chronic conditions [ 23 ], disability [ 24 ], loneliness [ 25 ], substance abuse [ 26 ], surgery [ 27 ], oncology [ 28 , 29 ], cardiology [ 30 , 31 ], nephrology [ 32 ], neurology [ 33 – 36 ], dermatology [ 37 ], ageing [ 38 – 40 ], or maternity [ 41 – 43 ], among others [ 44 – 48 ]. To our knowledge, no other study to date has used the SROI method in HA.…”

Section: Introductionmentioning

confidence: 99%

The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis

Soto

Mateo

García-Diego

et al. 2022

BMC Health Serv Res

Self Cite

View full text Add to dashboard Cite

Background Haemophilia A (HA) has been associated with poor health-related quality of life and a large economic burden, accentuated by severity, arthropathy, and inhibitors. To meet global standards of care, the management of HA should align with the principles of care outlined by the World Federation of Haemophilia. The aims of the present study were to establish a set of proposals to improve HA management within the Spanish National Health System (SNHS) and to estimate the impact its hypothetical implementation would generate from a clinical, healthcare, economic, and social perspective. Methods A multidisciplinary group of experts agreed on a set of 15 proposals to improve HA management within the SNHS. Thereafter, a forecast-type Social Return on Investment analysis was carried out to estimate the impact of implementing this set of proposals within the SNHS over a one-year timeframe, in relation to the required investment. Results This study estimated that the implementation of the complete set of 15 proposals would require a total investment of 2.34 M€ and have a total impact of 14.60 M€. Accordingly, every euro invested in the complete set of 15 proposals would yield a social return of €6.23 (€3.37 in the worst-case scenario and €9.69 in the best-case scenario) of both tangible and intangible nature in similar proportions (45.71 and 54.29%, respectively). Conclusions These results can be used to inform policy and practice such that interventions that may potentially improve current public health challenges associated with the management of HA may be implemented.

show abstract

“… 19 Despite the subjectivity associated with some of these methods, valuing intangible aspects without a market price is essential to expose social returns, usually associated with patient and caregiver needs, which would otherwise remain unaccounted for. Previous experiences have been used to guide decisions relative to healthcare interventions, 18 , 20–23 including interventions on chronic diseases overall, 24 heart failure, 25 psoriasis, 26 multiple sclerosis, 27 rheumatoid arthritis, 28 or haemophilia A, 29 among others. To date, no other study has used the SROI method to assess the impact of any healthcare intervention specifically designed for COPD.…”

Section: Introductionmentioning

confidence: 99%

A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System

Merino¹,

Lorenzo²,

Maravilla-Herrera³

et al. 2022

COPD

Self Cite

View full text Add to dashboard Cite

Purpose To define a set of proposals that would improve the current management of chronic obstructive pulmonary disease (COPD) within the Spanish National Healthcare System (SNHS) from a comprehensive multidisciplinary perspective and to assess the impact of its implementation from clinical, healthcare, economic, and social perspectives. Patients and Methods A group of 20 stakeholders related to COPD (healthcare professionals, patients, and informal caregivers, among others) participated in an online Delphi process to agree on a set of 15 proposals that would improve the current management of COPD within the SNHS in four areas: diagnosis, risk stratification, management of exacerbations, and management of stable COPD. A one-year forecast-type social return on investment (SROI) analysis was used to estimate the impact that implementing the set of proposals would have in relation to the investment required. A sensitivity analysis was used to test the strength of the model when varying assumption-based data-points. Results The hypothetical implementation of the complete set of 15 proposals would require a €668 million investment and would generate a €2079 million social impact concerning savings for the SNHS and quality of life improvements for patients and their informal caregivers, among others. Accordingly, for every euro invested in the set of proposals, a social return of €3.11 would be generated (€2.71 in the worst-case scenario and €3.62 in the best-case scenario) of both tangible (32.56%) and intangible nature (67.44%). Conclusion Altogether, implementing this set of 15 proposals would generate a positive social impact, threefold the required investment. The results may inform decisions relative to healthcare policy and practice regarding COPD management within the SNHS, further contributing to reduce the large burden of COPD.

show abstract

Multidisciplinary approach to psoriasis in the Spanish National Health System: A social return on investment study

Cited by 8 publications

References 41 publications

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation

The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis

A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System

Contact Info

Product

Resources

About